SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-006245
Filing Date
2017-02-06
Accepted
2017-02-06 17:25:13
Documents
64
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v457327_10q.htm 10-Q 308566
2 EXHIBIT 31.1 v457327_ex31-1.htm EX-31.1 10312
3 EXHIBIT 31.2 v457327_ex31-2.htm EX-31.2 10304
4 EXHIBIT 32.1 v457327_ex32-1.htm EX-32.1 4249
5 EXHIBIT 32.2 v457327_ex32-2.htm EX-32.2 4112
  Complete submission text file 0001144204-17-006245.txt   3556626

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sbot-20161231.xml EX-101.INS 839348
7 XBRL TAXONOMY EXTENSION SCHEMA sbot-20161231.xsd EX-101.SCH 41009
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbot-20161231_cal.xml EX-101.CAL 33389
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbot-20161231_def.xml EX-101.DEF 209022
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbot-20161231_lab.xml EX-101.LAB 278757
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbot-20161231_pre.xml EX-101.PRE 247936
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 17576533
SIC: 2834 Pharmaceutical Preparations